Amazon Q4 Preview: Asymmetric Downside If AWS Prints Below $34.9B In Revenue
seekingalpha.com
Want to monitor OMER?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor OMERomeros is a seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.